These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2123914)

  • 21. Effects of 5-isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis.
    Silva G; Segovia R; Ponce R; Backhouse C; Palma M; Roblero JP; Abadal J; Quijada C; Troncoso M; Iturriaga H
    Hepatogastroenterology; 2002; 49(47):1357-62. PubMed ID: 12239942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
    Bolognesi M; Sacerdoti D; Merkel C; Gatta A
    J Ultrasound Med; 1994 Dec; 13(12):945-52. PubMed ID: 7877205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portal and systemic hemodynamic responses to a very low dose of nitroglycerin in cirrhotic patients with portal hypertension.
    Kurokawa H; Sekiyama T; Katsuta Y; Aramaki T
    Nihon Ika Daigaku Zasshi; 1995 Feb; 62(1):2-12. PubMed ID: 7721974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C; López-Balaguer JM; Aracil C; Kolle L; González B; Miñana J; Soriano G; Guarner C; Balanzó J
    J Hepatol; 2004 May; 40(5):757-65. PubMed ID: 15094222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
    Bellis L; Berzigotti A; Abraldes JG; Moitinho E; García-Pagán JC; Bosch J; Rodés J
    Hepatology; 2003 Feb; 37(2):378-84. PubMed ID: 12540788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
    García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodynamic and functional hepatic effects of isosorbide-5-monitrate in cirrhotic patients with portal hypertension].
    Silva G; Fluxá F; Ruiz M; Bresky G; Barrientos C; Backhouse C; Palma M; Iturriaga H
    Rev Med Chil; 1993 Aug; 121(8):889-96. PubMed ID: 8296096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Portal hemodynamics during nitroglycerin administration in cirrhotic patients.
    Garcia-Tsao G; Groszmann RJ
    Hepatology; 1987; 7(5):805-9. PubMed ID: 3115881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
    Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J
    Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of isosorbide dinitrate, verapamil, and labetalol on portal pressure in cirrhosis.
    Freeman JG; Barton JR; Record CO
    Br Med J (Clin Res Ed); 1985 Aug; 291(6495):561-2. PubMed ID: 3929873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.
    Lin HC; Tsai YT; Lee FY; Chang TT; Wang SS; Lay CS; Lee SD; Lo KJ
    J Hepatol; 1990 May; 10(3):370-4. PubMed ID: 2114437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of peroral administration of isosorbide dinitrate on portal pressure and flow in patients with liver cirrhosis].
    Cervinka J; Kaláb M; Munclinger M; Kordac V; Tesar V; Marecek Z; Petrtýl J; Perlík F; Brodanová M; Ort J
    Cas Lek Cesk; 1988 Jan; 127(5):140-3. PubMed ID: 3356031
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis.
    Merkel C; Sacerdoti D; Bolognesi M; Buonamico P; Sticca A; Amodio P; Angeli P; Micotti L; Gatta A
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1221-5. PubMed ID: 10563530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H
    J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin.
    Hallemans R; Naeije R; Mols P; Mélot C; Reding P
    Crit Care Med; 1983 Jul; 11(7):536-40. PubMed ID: 6861502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intraportal nitroglycerin on portosystemic hemodynamics in patients with cirrhosis: comparison with i.v. route.
    Iwao T; Toyonaga A; Sumino M; Takagi K; Ohkubo K; Inoue R; Tanikawa K
    J Clin Gastroenterol; 1991 Aug; 13(4):424-31. PubMed ID: 1918848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM; Balas BI; Diculescu M
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.
    Ruiz del Arbol L; García-Pagán JC; Feu F; Pizcueta MP; Bosch J; Rodés J
    J Hepatol; 1991 Sep; 13(2):179-86. PubMed ID: 1744422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of isosorbide-5-mononitrate in reducing portal pressure in cirrhotic patients with cirrhosis and portal hypertension.
    Jenkins SA; Shields R
    J Gastroenterol Hepatol; 1991; 6(1):91-3. PubMed ID: 1883984
    [No Abstract]   [Full Text] [Related]  

  • 40. Duplex Doppler ultrasonographic comparison of the effects of propranolol and isosorbide-5-mononitrate on portal hemodynamics.
    Tincani E; Cioni G; Cristani A; D'Alimonte P; Vignoli A; Abbati G; Ventura P; Romagnoli R; Ventura E
    J Ultrasound Med; 1993 Sep; 12(9):525-9. PubMed ID: 8107184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.